baber/WOPTO huggingface dataset:
Patent FI-912598-A0 (FI)
Inventor: BAKER RAYMOND
IPC: C07D409/12
Filed: 1991-05-30
Abstract: A class of 2,4-dioxo-1,2,3,4-tetrahydroquinoline derivatives, substituted at the 3-position by a range of carbonyl-containing substituents or by a five- or six-membered heteroaromatic moiety, are selective non-competitive antagonists of NMDA receptors and/or are antagonists of AMPA receptors, and are therefore of utility in the treatment of conditions, such as neurodegenerative disorders, convulsions or schizophrenia, which require the administration of an NMDA and/or AMPA antagonist.
Patent FI-920287-A0 (FI)
Inventor: ALLAN G GRAHAM
IPC: D21H17/70
Filed: 1992-01-23
Abstract: There is disclosed a filled paper composition comprising intact cellulose fibers and fillers wherein the cellulose fibers are originally never-dried, and wherein the filler material is in an insoluble precipitate formed in situ within the cell wall of the never-dried cellulose pulp fibers. The filled paper composition is characterized by having increased strength characteristics relative to a corresponding conventionally loaded paper composition containing the same amount of the same filler material. There is also disclosed a process for the production of filled paper using never-dried pulp fibers and filler comprising an insoluble precipitate that is precipitated in situ within the cell wall of the fibers. The process first immerses the never-dried pulp fibers in a first solution containing a soluble salt or salts, filters the pulp fibers from the first solution, and reimmerses the never-dried pulp fibers containing the first solution in the pores into a second solution, wherein the second solution comprises soluble salt or salts different from those of the first solution and able to form an insoluble precipitate with the salt or salts of the first solution. The filled, never-dried pulp fibers are filtered and washed and either used to form filled paper products or dried to filled pulp fibers for later use in papermaking.
Patent FI-931748-A0 (FI)
Inventor: PEDERSEN LARS SAABY
IPC: C12S3/08
Filed: 1993-04-16
Abstract: PCT No. PCT/DK91/00315 Sec. 371 Date Mar. 3, 1993 Sec. 102(e) Date Mar. 3, 1993 PCT Filed Oct. 17, 1991 PCT Pub. No. WO92/07138 PCT Pub. Date Apr. 30, 1992.Resin can be hydrolyzed enzymatically during the reductive bleaching (e.g. with sodium dithionite) commonly used in pulp manufacture. The enzyme treatment necessitates little or no change of commonly used bleaching conditions.
Patent FI-931832-A0 (FI)
Inventor: HOUMAND JAN
IPC: G02C1/04
Filed: 1993-04-23
Abstract: PCT No. PCT/DK91/00322 Sec. 371 Date Apr. 26, 1993 Sec. 102(e) Date Apr. 26, 1993 PCT Filed Oct. 22, 1991 PCT Pub. No. WO92/08158 PCT Pub. Date May 14, 1992.A spectacle frame is fabricated by bending a piece of wire. The bends include eyelets or loops which are sized to accept therethrough the threaded shanks of plastic screws, but to stop the screw heads. The screws are passed through the eyelets and threaded into mating threaded holes in plastic lenses to attach the lenses onto the wire.
Patent FI-935886-A0 (FI)
Inventor: BADER ROLF
IPC: C07C211/46
Filed: 1993-12-27
Abstract: A process for the preparation of 2-alkyl-6-methyl-N-(1'methoxy-2'-propyl)-aniline by catalytic reductive alkylation wherein at least one mole equivalent of methoxyacetone is reacted with one mole equivalent of 2-alkyl-6-methyl-aniline in a liquid medium without an additional solvent, in the presence of a platinised carbon catalyst and hydrogen and in the presence of an acid cocatalyst under a hydrogen pressure of between 2 x 10<5> and 1 x 10<6> Pa at a temperature between 20 and 80  DEG C, characterised in that the reaction mixture contains water from the beginning of the reaction and after the hydrogenation, base is added, the reaction mixture is filtered to separate the catalyst and the title compound recovered from the filtrate. The process is particularly useful for the preparation of N-substituted chloracetanilide herbicides.
Patent FI-940041-A0 (FI)
Inventor: MOHACSI ERNO
IPC: A61K31/435
Filed: 1994-01-05
Abstract: The use of a compound of the formula: <CHEM>  wherein R<2> is aryl, heteroaryl or a group of the formula R<2><0> <CHEM> and R<1> is hydrogen, alkyl, a group of the formula -C(Y,Y<1>)CH2OH or -CH2W, wherein one of Y and Y<1> is hydrogen and the other is alkyl or both Y and Y<1> are alkyl and W is cycloalkyl, aryl or allyl and pharmaceutically acceptable salts thereof, for the manufacture of a medicament for reducing adverse effects of toxic injury to central neurons, particularly wherein the injury to central neurons is associated with ischemia, hypoxia, hypoglycemia, epilepsy, Huntington's disease or Alzheimer's disease, or for treating convulsions. The novel compounds of formula I wherein R<2> is substituted or unsubstitued pyridyl, thiazolyl, thienyl, phenyl, or a group of the formula R<2><0> and R<1> is hydrogen, alkyl, or a group of the formula -C(Y, Y<1>)CH2OH, wherein one of Y and Y<1> is hydrogen and the other is alkyl or both Y and Y<1> are alkyl, provided that when R<2> is pyridyl or phenyl, R<1> is other than alkyl, and pharmaceutically acceptable salts thereof.
Patent FI-944047-A0 (FI)
Inventor: DOUGLAS STEPHEN JOHN
IPC: A61K33/24
Filed: 1994-09-02
Abstract: Pharmaceutical prepn. comprises: (a) a salt of ranitidine (I) with a bismuth complex of tartaric or citric acid; and (b) an alkali salt. Pref., the salt is e.g. -N-(Q)-N'-methyl-2-nitro -1,1-ethenediamine-2-hydroxy -1,2,3-propanetricarboxylate -bismuth (3+).
Patent FI-952628-A0 (FI)
Inventor: HORN UTE
IPC: D21H19/40
Filed: 1995-05-30
Abstract: The prodn. of fine aq. dispersions of organophilic layer silicates (I) comprises reacting a cation-exchanging layer silicate (II) with a quat. organic onium salt (III) in an aq. medium in the presence of a water soluble hydrogen (IV). Also claimed are: (a) a cardboard or paper coated with aq. dispersion (I), and (b) dispersions (I) obtd. by this process.
Patent AP-9901538-A0 (AP)
Title: 8-Azabicyclo(3,2,1) octane-88-azabicycle(3,2,1) oct-6-ene-, 9- azabicycle(3,3,1) nonana-9-aza-3- oxabicylo(3,3,1) nonane-and 9-aza-3- thiabicyclo(3,3,1) nonane derivatives, their preparation and their use as insecticides.
Inventor: BRIGHTWELL CHRISTOPHER IAN
IPC: C07D265/00
Filed: 1997-11-06
Abstract: A compound of formula (i)wherein a represents a bidentate group of the formula -ch2-x-ch2- (wherein x is methylene, sulfur or oxygen), x'c=cy or x'wc-cyz (wherein x, w, y and z are independently hydrogen, hydorxy, acyloxy, alkoxy, alkylsilyloxy, cyano or halogen, or x' and w or y and z together with the carbon to which they are attached form a carbonyl group), provided that a is not ch2-ch2; ar is an optionally substituted phenyl or 5- or 6-membered heterocyclic ring system containing from 1 to 3 heteroatoms individualy slected from nitrogen, oxygen and sulfur atoms, and at least one unsaturation (double bond)between adjacent atoms in the ring, said heterocyclic ring being optionally fused to a benzene ring, wherein the substituents, if present, are selected from halogen atoms, cyano, alkyl, alkenyl, alkynyl, alkoxy, haloalkenyl, alkylthio and alkyl amino groups, any of which groups contain up to six carbon atoms; r is hydrogen or cyano or a group selected from alkyl, aryl, heteroaryl, aralkyl, heteroarylalkyl, alkenyl, aralkenyl, alkynyl, alkoxycarbonyl, alkanesulfonyl, arenesulfonyl, aldenyloxycarbonyl, aralkylocycarbonyl, aryloxycarbonyl, heterocyclylakyl, carbamyl, dithiocarboxyl or x
Patent IL-71205-A0 (IL)
Title: Device for gathering a portion of an article made of fabric and/or nonwoven fabric and for the stable retention of said portion in a gathered position
IPC: D04B25/10
Filed: 1984-03-09
Abstract: The present invention relates to a device for gathering a portion of an article made of fabric and/or non-woven fabric for the stable retention of said portion in said gathered position, consisting of ribbon-shaped and/or cord-like elements slidable within seatings formed for the purpose in the fabric. Said ribbon-shaped and/or cord-like elements comprise a first element, restrained at one end within said seating, connected to a second element protruding freely from said seating, such connection being made at two portions of the two elements, the portion of one of said elements being moreover larger than that of the other and said larger portion having a first rigid lamina at least partially restrained to it.
Patent IL-76136-A0 (IL)
Title: Preparation of o-alkyl s-(alpha-branched alkyl)alkylphosphonothioates
IPC: C07F9/40
Filed: 1985-08-19
Abstract: Process for preparing an O-alkyl S-(alpha-branched alkyl) alkylphosphonothioate of formula:   <IMAGE>   with R and R1=alkyl having 1 to 8 C. R2=alpha-branched alkyl having 3 to 8 C. It consists in reacting an O-(alkyl)alkylphosphonic acid halide with an alkyl mercaptan HSR2 in an organic medium, in the presence of an acceptor for acid and a smaller amount of an auxiliary base. Process useful for preparing insecticidal and nematocidal products.
Patent IL-88087-A0 (IL)
Title: Stabilized pergolide compositions
IPC: A61K31/48
Filed: 1988-10-19
Abstract: Pharmaceutical compositions containing pergolide or pharmaceutically-acceptable salts thereof stabilized to decomposition by light by incorporation therewith of a stabilizing agent selected from polyvinylpyrrolidone,  alpha -tocopherol succinate and propyl gallate.
Patent AU-PQ905600-A0 (AU)
Title: Parasites
IPC: C12Q1/04
Filed: 2000-07-28
Abstract: The present invention relates to a novel Neospora caninum isolate from Nowra and extracts thereof. The strain is useful in the development of diagnostic assays for the detection of parasites in animals. The present invention also relates to pharmaceutical compositions, using live or killed organisms or extracts thereof, for the treatment and prevention of parasitic infections in animals.
Patent FI-20002518-A0 (FI)
IPC: H05B41/392
Filed: 2000-11-16
Abstract: An arrangement in connection with a discharge lamp, the arrangement comprising an electronic ballast for igniting and burning the discharge lamp (4), and a voltage control device arranged to modify supply voltage of the ballast. The voltage control device is further arranged to include a power control signal in the supply voltage. The arrangement further comprises a power filter (2) and a control filter (1) for separating the power control signal (p) from the supply voltage (Uin), the ballast being responsive to the power control signal (p) in order to control the level of light of a fluorescent tube (4). <IMAGE>
Patent FI-20050015-A0 (FI)
Inventor: JAERVINEN LASSI
IPC: B28B1/08
Filed: 2005-01-07
Abstract: Method and apparatus for casting a concrete product with a substantially horizontal slipform casting process, wherein the concrete mix is fed at least in one step through a limited cross-section moving progressively along with the cast, whereby the height of the product forming part (1) is changed during the cast. The invention also comprises a product forming part (1) having an adjustable height.
Patent FI-20060533-A0 (FI)
Inventor: DOROKHOV YURI LEONIDOVICH
IPC: A61K/
Filed: 2006-06-01
Abstract: The present invention provides constructs and methods for expression and accumulation of tuberculosis vaccine proteins in tissue or organ of a plant. The proteins are obtained by transient expression in and/or stable transformation of plants with non-replicating genes or virus-based vector cDNAs encoding the proteins. The genes include cellular compartment-specific, regulatory and/or affinity purification tag sequences. The plant tissue fractions containing the tuberculosis vaccine proteins themselves or after purification are useful as a tuberculosis vaccine.
Patent IL-107642-A0 (IL)
Title: Progenitor b cell stimulating factor
IPC: C07K14/555
Filed: 1993-11-17
Abstract: A progenitor B cell stimulating factor which promotes the formation of pre-B cells is described. DNA sequences encoding same and methods of production and purification of the factor are also disclosed. The factor is used in the treatment of hematopoietic disorders and in bone marrow transplantation.
Patent IL-112118-A0 (IL)
Title: Diazabicyclic neurokinin antagonists
IPC: A61P37/04
Filed: 1994-12-22
Abstract: The present invention relates to diazabicyclic compounds and, specifically, to compounds of the formula wherein A, G, R1, R2, R3, R41 R5, R6, and R7 are as defined in the specification. The compounds of formula I are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
Patent IL-119164-A0 (IL)
Title: Iontophoretic treatment system
IPC: A61N1/32
Filed: 1996-08-30
Abstract: A method and apparatus for applying iontophoretic treatment to a biological subject wherein electrical treatment current between a pair of electrodes is periodically reversed at very low frequencies, substantially in the range of approximately 0.0027 Hz to approximately 10 Hz, to mitigate tissue damage, enable long term dosimetry with single and multiple drugs of any polarity and at higher concentrations, and eliminate the need for buffering agents and the like, all in a relatively simple, economical and compact physical packaging configuration. The system delivers treatment substances with large and/or small molecular size and weight and can be adjusted to control pH at the delivery site. A method of lowering resistance and enhancing permeability at the delivery site, as well as increasing drug concentrations and delivery rates. <IMAGE>
Patent IL-138110-A0 (IL)
Title: 6the use of fumaric acid derivatives in transplant medicine
IPC: A61K31/19
Filed: 1999-08-20
Abstract: The invention relates to the use of certain fumaric acid monoalkyl esters as salts or a free acid either alone or in combination with a dialkyl fumarate for producing pharmaceutical preparations for use in transplantation medicine, especially for treating, alleviating or suppressing host-versus-graft reactions. For this purpose, the fumaric acid monoalkyl esters may be used in combination with preparations conventionally used in transplantation medicine and immuno suppressives, especially such as cyclosporines.
Patent IL-141160-A0 (IL)
Title: A pharmaceutical composition containing a precursor of uric acid
IPC: A61K31/355
Filed: 1999-08-02
Abstract: Damage to cells, tissue and other body parts in a mammalian host may be treated by using hypoxanthine and in conjunction with at least one biological modifier, which may be a free radical scavenger or a metabolic inhibitor. The biological modifier is preferably uric acid, buthionine sulphoximine, vitamin C, aspirin, or nordihydroguaiaretic acid. Such a combination may be used to treat, for example, cancer, infectious diseases, neurodegenerative disease and damage caused by radiation therapy, high oxygen tension, and chemotherapy.
Patent IL-142270-A0 (IL)
Title: Method and device to correct the variation in the qdm of a navigation system
IPC: G01S1/02
Filed: 2001-03-27
Abstract: A method to correct the drift in the phase shift between first and second signals, the first and second signals generated by a signal having frequency Fe, the drift in the phase shift resulting from a drift in the frequency Fe, according to a given relationship. In one embodiment, the method includes the steps of (1) determining a value of the phase shift from a phase of the first signal and a phase of the second signal, (2) estimating the value of the frequency Fe, and (3) adjusting the phase shift to a value within an interval of angular values containing the angular value obtained for a reference value, using the phase shift, the estimated value of the frequency, and the given relationship.
Patent IL-152728-A0 (IL)
Title: 2-substituted pregna-1,3,5 (10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
IPC: C07J41/00
Filed: 2001-05-11
Abstract: Compounds of formula (I) in which: R<1> represents a hydrogen atom or an O-protecting group; R<2> represents a hydroxyl, lower alkoxy, carboxaldehyde, lower alk-1-enyl or hydroxy- or lower alkoxy-substituted lower alkyl group; R<3> represents a methyl group having  alpha - or  beta - configuration; X represents a C1-3 alkylene group or a valence bond; Y represents a carboxaldehyde group or a group of formula -C(R<4>) (R<5>)OR<1> where R<1> is as defined above and R<4> and R<5>, which may be the same or different, are each selected from hydrogen atoms, alkyl, alkenyl and alkynyl groups such that the total carbon content of R<4> and R<5> does not exceed three atoms, with the proviso that X is a valence bond when both R<4> and R<5> are other than hydrogen; and the dotted line signifies that a double bond may optionally be present at the 16(17) -position exhibit potent cell modulating activity, including antiproliferative and antiangiogenic effects.
Patent IL-152803-A0 (IL)
Title: Polyacrylamide hydrogel and its use as an endoprosthesis
IPC: A61L27/16
Filed: 2001-08-25
Abstract: The invention concerns a hydrogel for use in the treatment of arthritis, said hydrogel obtainable by combining acrylamide and methylene bis-acrylamide in amounts so as to give about 0.5 to 25% by weight polyacrylamide, based on the total weight of the hydrogel; radical initiation; and washing with pyrogen-free water or saline solution. The preferred treatment is by injection of the hydrogel into the intra-articular cavity of a joint.
Patent IL-156884-A0 (IL)
Title: Assemble-in-place modular storage
IPC: A47B47/00
Filed: 2002-01-11
Abstract: A modular storage rack, display structural element or cube system formed by snap together panels with alignment guides, which may also support wheels, shelves, drawers and doors. The system is assemble-in-place and may shipped and displayed for sale in a flat pack.
Patent IL-176276-A0 (IL)
Title: [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINE DERIVATIVES
IPC: A61K31/519
Filed: 2002-11-21
Abstract: Pyrimidines of formula I in which R<SUP>1 </SUP>represents hydrogen or alkyl, haloalkyl, alkenyl, alkynyl, alkadienyl, alkoxy, cycloalkyl, phenyl, or 5- or 6-membered heteroaryl or 5- or 6-membered heterocyclyl, containing one to four nitrogen atoms or one to three nitrogen atoms and one sulfur or oxygen atom, or tri-alkyl-silyl, formyl or alkoxy-carbonyl, wherein R<SUP>1 </SUP>groups are unsubstituted or substituted as defined in the specification; R<SUP>2 </SUP>represents phenyl, cycloalkyl or 5- or 6-membered heteroaryl, containing one to four nitrogen atoms or one to three nitrogen atoms and one sulfur or oxygen atom, which are unsubstituted or substituted; R<SUP>3 </SUP>represents hydrogen, halogen or alkyl, alkoxy, alkylthio, alkylamino or dialkylamino; which are unsubstituted or substituted; R<SUP>4 </SUP>represents hydrogen or alkyl, alkenyl or alkynyl; which are unsubstituted or substituted; and X represents O, S, NR<SUP>5 </SUP>or a single bond, wherein R<SUP>5 </SUP>represents hydrogen or alkyl; or R<SUP>1 </SUP>and R<SUP>5 </SUP>together with the interjacent nitrogen atom form a heterocyclic ring; processes and intermediates for preparing these compounds, to compositions comprising them and to their use for controlling harmful fungi.
Patent IL-182503-A0 (IL)
Title: Anti-il-22ra antibodies and binding partners and methods of using in inflammation
Filed: 2007-04-12
Abstract: The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-22, IL-20, or both IL-20 and IL-22 polypeptide molecules. IL-20 and IL-22 are cytokines that are involved in inflammatory processes and human disease. IL-22RA (zcytor11) is a common receptor for IL-20 and IL-22. The present invention includes anti-IL-22RA antibodies and binding partners, as well as methods for antagonizing IL-22 or both IL-20 and IL-22 using such antibodies and binding partners.
Patent RO-128776-A0 (RO)
Title: Device for extracting and conveying gas samples
Inventor: BECEA GRIGORE
IPC: E21B49/08
Filed: 2013-02-14
Abstract: The invention relates to a device for extracting and conveying a sample of gas from the drilling fluid, while making a borehole, for determining both the gas/fluid ratio and the chemical composition of the gas. According to the invention, the device comprises a vertical tube () provided at the lower end with a lateral connection () through which there is injected the air that entrains the drilling fluid (), wherein the tube () is partially immersed into a biphasic ascending turbulent flow in order to be discharged into another large vertical tube () by means of a horizontal connection tube (), at the upper part of the large tube () there being mounted a connection () for extracting the gas/air mixture and a float () driving a valve () for the intake of fresh air and for the adjustment of the fluid level.
Patent RO-132787-A0 (RO)
Title: Process for carrying-out elevation digital model by using a small-sized lidar-uav system, of less than 15 kg
Inventor: BALOTĂ OCTAVIAN LAURENŢIU
IPC: G06T17/05
Filed: 2018-04-25
Abstract: The invention relates to a process for carrying-out an elevation digital model of a geographical area. According to the invention, the process consists in making a project (B) of data gathering by using a LIDAR sensor mounted on an unassisted air-vehicle (UAV) provided with positioning equipments of GNSS type and inertial type, IMU, and establishing the recording area, the calibration (A) of the LIDAR sensor position in relation to the inertial system and to the GNSS system antenna position, performing the flight (C) and obtaining LIDAR raw data (1) which are then geometrically calibrated by means of a process of physical and geometrical error correction, starting from the navigation data generated based on the determination (N) of a compensated flight trajectory, LIDAR data which are then validated through a quality control process (I) for obtaining a calibrated point cloud (5), wherefrom the improbable points are removed by statistical control processes (J), and georeferenced in a desired coordinate system, from which the field digital model and the surface digital model are finally obtained.
Patent MC-1737-A1 (MC)
Inventor: DESPRES JEAN-ALBERT
IPC: G09F3/00
Filed: 1986-02-17
Abstract: The present invention essentially relates to a method for identifying a valuable object such as for example an object d'art or like work, product or object of artistic value, consisting in incorporating in an invisible manner into the said object an element provided with a code, wherein the information corresponding to the code on the element is centralized in a computer with an associated file allowing the object to be identified with certainty.
Patent ZM-1287-A1 (ZM)
Title: Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
IPC: C07D405/14
Filed: 1987-02-02
Abstract: Pharmaceutical compsn. comprises as active ingredient a therapeuticall effective ant. of an N-(4-piperidinyl)-3H-imidazo (4,5-b) pyridine-2-amine or N-(4-piperidinyl)-1H-benzimidazole-2-amine cpd. of formula (I) or its pharmaceutically acceptable acid addn. salt or steroisomer: where L=H, 1-6C alkoxy-carbonyl or benzyloxyearbonyl, A= gp. of formula (a) -CH=CH-CH=CH-, (b) -N=CH-CH=CH-, (c) -CH2N-CH=CH-, (d) -CH0CH-N=CH- or (e) -CH=CH-CH=N-, where 1 or 2 H atoms of (a) - (e) may be replaced by halogen, 1-6C alkyl, 1-6C alkoxy, CF3 and/or OH gp(s).; R= H or 1-6C alkyl; R1=H, 1-10C alky, 3-6C cycloalkyl, Ar1 or 1-6C alkyl substd. by 1 or 2 Ar1; R2= H, 1-6C alkyl, 3-6C cycloalkyl, 1-6C alkyl -(O-, 1-6C alkoxy-CO- or Ar2 - 1-6C alkyl; Ar1 = phenyl (opt. substd. by 1-3 of halogen, OH, N02, CN CF3, 1-6C alyl, 1-6C alkoxy, 1-6C alkylthio, SH, NH2, mono-or di-(1-6C alkyl)-amino, carboxyl, 1-6C alkoxy -carbonyl and/or 1-6C alkyl -co-), thienyl, halothienyl, furanyl, 1-6C alkyl-furanyl, pyridinyl, pyraxinyl, thiazolyl or imidazolyl opt. substd. by 1-6C alkyl, and Ar2 = phenyl opt. substd. as in Ar1. Cpds. of formula (I) and salts and stereoisomers are new where R1=R1a= 1-6C alkyl substd. with 1-6C alkyl-substd. furanyl other than 5-methyl-2-furanyl.